Office of Inspector General, U.S. Department of Health and Human Services

"I'm in a constant state of fear," New Survey Reveals Black Girls & Youth of Color Still Hold Negative Views of Police

Retrieved on: 
Thursday, October 26, 2023
Grief, Mental, Gender responsive approach for girls in the juvenile justice system, United States Department of Justice, Gender, Delinquent, Racism, The Power, Numb, Anger, Fear, Trauma, Collaborative RESearch Team to study psychosocial issues in Bipolar Disorder, Justice, RSVP, Juvenile court, Violence, School, AAPI, Police, Culture, Safety, Office of Inspector General, U.S. Department of Health and Human Services, Parent, Mental health, Toy, Nightclub, Drug

"Young people have a right to feel safe and live freely," said Jeannette Pai-Espinosa, president of Justice + Joy.

Key Points: 
  • "Young people have a right to feel safe and live freely," said Jeannette Pai-Espinosa, president of Justice + Joy.
  • Despite a decline in justice-involved youth, the proportion of girls involved has increased over time, and data shows Black youth experience more violent interactions with police than their white peers.
  • 75.4% of Black girls and gender-expansive survey participants fear becoming victims of police brutality.
  • "As a young Black woman, I'm in a constant state of fear which causes a heightened sense of awareness.

Zefiro Methane Corp. Co-Hosts U.S. Department of the Interior & New York State Officials at Successfully Plugged Oil Well Site

Retrieved on: 
Thursday, October 26, 2023
WALES, Environmental protection, METHANE, Plant, News, Carbon, Organization, New York State Department of Environmental Conservation, Methane, Empire State, Drinking water, P&G, Office of Inspector General, U.S. Department of Health and Human Services, Interior, Government, State government, Renewable energy, Management, Zefiro

SOUTH WALES, N.Y., Oct. 26, 2023 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (the “Company”, “Zefiro”, or “ZEFI”) which works to reduce methane emissions by plugging orphaned oil and gas wells across the U.S., yesterday co-hosted U.S. Department of the Interior ("DOI") Infrastructure Coordinator Winnie Stachelberg and several officials from the New York State Department of Environmental Conservation (“NYSDEC”) at an oil well the Company helped successfully plug in South Wales, New York.

Key Points: 
  • SOUTH WALES, N.Y., Oct. 26, 2023 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (the “Company”, “Zefiro”, or “ZEFI”) which works to reduce methane emissions by plugging orphaned oil and gas wells across the U.S., yesterday co-hosted U.S. Department of the Interior ("DOI") Infrastructure Coordinator Winnie Stachelberg and several officials from the New York State Department of Environmental Conservation (“NYSDEC”) at an oil well the Company helped successfully plug in South Wales, New York.
  • According to the latest projections, there are more than four million abandoned wells scattered across 26 U.S. states, including over approximately 23,000 unplugged sites in New York state alone.
  • October 25, 2023: Zefiro Founder and Executive Chairman Talal Debs is pictured with DOI Infrastructure Coordinator Winnie Stachelberg at the site of an oil well successfully plugged by Zefiro and P&G in South Wales, NY
    Readers using news aggregation services may be unable to view the media above.
  • Please access the Investors section of the Company’s website for a version of this press release containing all published media.

NatureSweet Partners with Industry Leaders to Encourage the Department of Commerce to Keep Fresh Tomatoes Available, Affordable for American Consumers

Retrieved on: 
Thursday, October 26, 2023
Organic Food, White House, Federal Government, Public Policy, Government, Retail, Food, Beverage, Idaho Department of Commerce, Commerce, NatureSweet, Office of Inspector General, U.S. Department of Health and Human Services, Education, U.S. Department of Commerce Office of Security, General counsel, Commerce Department trade mission controversy, Agriculture, Grocery store

A small group of domestic tomato producers is petitioning the Department of Commerce to terminate a longstanding trade agreement between the United States and importers of fresh tomatoes from Mexico.

Key Points: 
  • A small group of domestic tomato producers is petitioning the Department of Commerce to terminate a longstanding trade agreement between the United States and importers of fresh tomatoes from Mexico.
  • “The suspension agreement is critical to keeping specialty tomato varieties on American grocery store shelves,” says Skip Hulett, Vice President of General Counsel for NatureSweet.
  • Importers continue to play by the rules to deliver fresh, quality tomatoes to American families.
  • NatureSweet will continue to partner with industry leaders to encourage Commerce to reach a resolution that allows economies on both sides of the border to continue thriving.

Real Adoptive Parents and Teens Choose Each Other in New Heartwarming PSAs

Retrieved on: 
Thursday, October 26, 2023
HHS, United States Children's Bureau, Second-parent adoption, Television, Advertising, Council, Private sector, Youth, Gold Lion, U.S. Department of Defense Strategy for Operating in Cyberspace, Sustainable Development Goal 5, Parent, Mental health, PR, ACYF, Child, Love, Human, Organization, Intuition, Office of Inspector General, U.S. Department of Health and Human Services, Marketing, Lead, Provocation, United States House Select Committee on Children, Youth, and Families, Safety, Sport, Radio, Reward, Research, Smokey Bear, ACF, Hearing, Family, United States Department of Health and Human Services, Administration, Commissioner, PSAS, Administration for Children and Families, Disability, Ad Council, Edelman, Sustainable Development Goals, Sales, Toy, Residential care

WASHINGTON, Oct. 26, 2023 /PRNewswire/ -- The U.S. Department of Health and Human Services (HHS), Administration for Children and Families (ACF), AdoptUSKids, and the Ad Council today launched moving new public service advertisements (PSAs) that encourage prospective parents to adopt teens from foster care. Created by Edelman, the PSAs build on the campaign's "You Can't Imagine the Reward" message and feature real adoptive families sharing their adoption from foster care stories and how rewarding the journey has been for both parents and teens.

Key Points: 
  • A common misconception about teen adoption is that the decision to adopt is driven solely by adoptive parents, but in reality, teens also have an active role in that choice.
  • New PSAs, " Parents Adopted ," developed pro bono by Edelman celebrate how teens and adoptive parents actively choose each other and showcase adoptive parents talking about how they too were "adopted" by their teens.
  • Together, adoptive parents and teens talk openly about choosing to be each other's family and how they've built and fostered a life of deep and mutual rewards.
  • By inviting prospective parents to hear from these six dynamic and relatable families, the new PSAs help viewers see themselves as potential adoptive parents.

EQS-News: BB BIOTECH AG: Biotech equity markets in flux: the impact of rising bond yields and shifting healthcare policies

Retrieved on: 
Thursday, October 26, 2023
Neoplasm, FDA, Federal Trade Commission, HHS, Attention, Chronic inflammatory demyelinating polyneuropathy, Ovarian cancer, Frankfurt Stock Exchange, NASDAQ Biotechnology Index, Government, Obesity, Fundamental, DSM-IV codes, Alnylam Pharmaceuticals, CAH, Neurocrine, Posture, SIX Swiss Exchange, Office of Inspector General, U.S. Department of Health and Human Services, Zuranolone, Congenital adrenal hyperplasia, Biotechnology, Inflation Reduction Act of 2022, Hypertension, NBI, Amgen, NET, Depression, BB Biotech, Platinum, NAV, CIDP, Woman, FTC, Inflation, Investment, Therapy, Patient, Cabozantinib, CHF, POC, Security (finance), Rare-earth element, Public utility, Pharmaceutical industry, Bank, Vertex, Incyte, EUR, USD, Valbenazine

BB BIOTECH AG: Biotech equity markets in flux: the impact of rising bond yields and shifting healthcare policies

Key Points: 
  • BB BIOTECH AG: Biotech equity markets in flux: the impact of rising bond yields and shifting healthcare policies
    The issuer is solely responsible for the content of this announcement.
  • The rise in bond yields weighed heavily on biotech stocks as well as the stock market in general.
  • BB Biotech benefited from the dollar's appreciation, but it was also exposed to the sustained selling pressure on equity markets.
  • BB Biotech traded within a narrow range during the third quarter, closing slightly higher at CHF 41.35 per share.

MeMed awarded US BARDA contract to demonstrate clinical utility of the FDA-cleared MeMed BV® test for distinguishing bacterial from viral infections

Retrieved on: 
Tuesday, October 24, 2023
MA, FDA, Global health, Biomedical Advanced Research and Development Authority, Human services, BARDA, Administration, Development, Meme, Administration for Strategic Preparedness and Response, Drive, Division, Office of Inspector General, U.S. Department of Health and Human Services, Randomized controlled trial, United States Department of Defense, Pharmaceutical industry, Medical device, Research

The contract will support the execution of a randomized controlled trial designed to build on existing clinical utility data demonstrating that MeMed BV can improve patient outcomes.

Key Points: 
  • The contract will support the execution of a randomized controlled trial designed to build on existing clinical utility data demonstrating that MeMed BV can improve patient outcomes.
  • The FDA-cleared MeMed BV test is a pioneering host response-based diagnostic tool.
  • Eran Eden, CEO of MeMed, said: "We are committed to generating the highest level of clinical utility evidence to establish the impact of MeMed BV on improving patient outcomes.
  • This contract follows U.S. Department of Defense funding that supported development of MeMed Key, a platform to rapidly measure MeMed BV that will be employed in the trial,” commented Tanya Gottlieb, VP Scientific Affairs at MeMed.

MeMed awarded US BARDA contract to demonstrate clinical utility of the FDA-cleared MeMed BV® test for distinguishing bacterial from viral infections

Retrieved on: 
Tuesday, October 24, 2023
MA, FDA, Global health, Biomedical Advanced Research and Development Authority, Human services, BARDA, Administration, Development, Meme, Administration for Strategic Preparedness and Response, Drive, Division, Office of Inspector General, U.S. Department of Health and Human Services, Randomized controlled trial, United States Department of Defense, Pharmaceutical industry, Medical device, Research

The contract will support the execution of a randomized controlled trial designed to build on existing clinical utility data demonstrating that MeMed BV can improve patient outcomes.

Key Points: 
  • The contract will support the execution of a randomized controlled trial designed to build on existing clinical utility data demonstrating that MeMed BV can improve patient outcomes.
  • The FDA-cleared MeMed BV test is a pioneering host response-based diagnostic tool.
  • Eran Eden, CEO of MeMed, said: "We are committed to generating the highest level of clinical utility evidence to establish the impact of MeMed BV on improving patient outcomes.
  • This contract follows U.S. Department of Defense funding that supported development of MeMed Key, a platform to rapidly measure MeMed BV that will be employed in the trial,” commented Tanya Gottlieb, VP Scientific Affairs at MeMed.

Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Marburg Vaccine in Uganda

Retrieved on: 
Thursday, October 19, 2023
Biomedical Advanced Research and Development Authority, Guinea, Makerere University Walter Reed Project, Sabin Vaccine Institute, Vaccine, Family, Human services, Kenya Medical Research Institute, Administration for Strategic Preparedness and Response, Viral hemorrhagic fever, Organization, BARDA, United States Department of Health and Human Services, Research, Volunteering, Administration, Development, Epidemic, Disease, Clinical trial, Blood, Safety, Office of Inspector General, U.S. Department of Health and Human Services, Polio, Marburg virus disease, Medical device, Pharmaceutical industry

WASHINGTON, Oct. 19, 2023 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute has launched a Phase 2 clinical trial for its vaccine candidate against the lethal Marburg virus. Healthy volunteers received the single-dose vaccine at Makerere University Walter Reed Project (MUWRP) in Kampala, Uganda today.

Key Points: 
  • WASHINGTON, Oct. 19, 2023 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute has launched a Phase 2 clinical trial for its vaccine candidate against the lethal Marburg virus.
  • “Makerere University Walter Reed Project (MUWRP) is delighted to partner with the Sabin Vaccine Institute to launch the clinical testing for a preventive Marburg vaccine,” says Dr. Mwesigwa.
  • In addition to the current trial in Uganda and Kenya, Sabin plans to conduct a similar Phase 2 clinical trial for Marburg in the U.S.
  • Sabin has also initiated plans for a Phase 2 Sudan ebolavirus vaccine clinical trial in Uganda and Kenya.

Castellum.AI raises $4M in Spider Capital-led Round to Scale Compliance Screening for Enterprises

Retrieved on: 
Wednesday, October 25, 2023
Other Policy Issues, Data Management, Technology, Homeland Security, Congressional News, Views, Logistics, Supply Chain Management, Public Policy, Government, Other Professional Services, Legal, Insurance, Finance, Consulting, Security, Banking, Transport, Professional Services, Artificial Intelligence, White House, Federal Government, Internet, Digital, Castellum, Treasury, News, Organization, Entrepreneurship, Engineering, Non-governmental organization, KYC, API, Office of Inspector General, U.S. Department of Health and Human Services, Investment, Pain, AML, Medical device, Cryptocurrency

Castellum.AI has built the most accurate, reliable and fastest global risk data platform, enabling KYC and AML compliance teams to reduce false positives by 80%.

Key Points: 
  • Castellum.AI has built the most accurate, reliable and fastest global risk data platform, enabling KYC and AML compliance teams to reduce false positives by 80%.
  • Their lists are updated every 5 minutes, so I never have to worry.”
    Castellum.AI additionally partners with companies across the compliance industry.
  • “We are really excited to partner with Castellum.AI, which enables us to enhance our AML/KYC compliance solutions with best-in-class compliance data.
  • Search global risk data for free at Castellum.AI to discover why top compliance teams have transitioned from legacy systems.

WebMD Ignite and Freshpaint Bring a Privacy-First Approach to High-Performance Healthcare Marketing

Retrieved on: 
Tuesday, October 24, 2023
Federal Trade Commission, HHS, HIPAA, SVP, Organization, Google Analytics, Learning, WebMD, Ecosystem, Partnership, Hospital, Paramount, Privacy, Privacy Office of the U.S. Department of Homeland Security, Office of Inspector General, U.S. Department of Health and Human Services, FTC, Meta Platforms, Medical device, Health

NEW YORK, Oct. 24, 2023 /PRNewswire/ -- Today, WebMD Ignite , a full-service growth partner for organizations across the healthcare industry, announced a strategic partnership with Freshpaint , a healthcare privacy platform that allows healthcare providers to continue doing high-performance marketing while protecting patient privacy.

Key Points: 
  • NEW YORK, Oct. 24, 2023 /PRNewswire/ -- Today, WebMD Ignite , a full-service growth partner for organizations across the healthcare industry, announced a strategic partnership with Freshpaint , a healthcare privacy platform that allows healthcare providers to continue doing high-performance marketing while protecting patient privacy.
  • Together, the partnership enables healthcare organizations to take a privacy-first approach to high-performance marketing by:
    "Getting the right information to the right people is critical in a healthcare setting.
  • Existing WebMD Ignite clients will have their products configured and powered by Freshpaint to manage their privacy and data settings.
  • Organizations interested in learning more can contact their WebMD Ignite or Freshpaint representative, or visit webmdignite.com to connect with the team.